India's 2nd-largest pharmacy retail chain, running 5,330+ neighbourhood stores plus diagnostics and omni-channel delivery.
Price
Market Cap
Sector
Consumer Discretionary
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 0 | 0 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 528 | 730 | 1.4k | 1.5k | 1.6k | 1.7k | 1.8k | 2.0k |
| Borrowings | 477 | 590 | 815 | 900 | 1.0k | 1.1k | 1.2k | 1.4k |
| Other Liabilities | 344 | 245 | 361 | 406 | 417 | 500 | 534 | 533 |
| Total Liabilities | 1.3k | 1.6k | 2.6k | 2.8k | 3.0k | 3.4k | 3.6k | 3.9k |
| AssetsFixed Assets | 419 | 517 | 799 | 1.1k | 1.2k | 1.3k | 1.4k | 1.6k |
| CWIP | 5 | 6 | 20 | 25 | 11 | 16 | 17 | 32 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 924 | 1.0k | 1.8k | 1.6k | 1.8k | 2.0k | 2.2k | 2.3k |
| Total Assets | 1.3k | 1.6k | 2.6k | 2.8k | 3.0k | 3.4k | 3.6k | 3.9k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 147 | -7 | 3 | 170 | 90 | 144 | 540 | 496 |
| Cash from Investing | -19 | -28 | -35 | -703 | 429 | -83 | -318 | -128 |
| Cash from Financing | -83 | 90 | -6 | 440 | -170 | -198 | -228 | -256 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 125 | -37 | -51 | 56 | -78 | 61 | 482 | 373 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
MEDPLUS · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.